356 related articles for article (PubMed ID: 16000612)
21. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
[TBL] [Abstract][Full Text] [Related]
22. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
Kubota K
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
[TBL] [Abstract][Full Text] [Related]
23. [Concurrent chemoradiotherapy for stage III non-small cell lung cancer].
Hou HL; Hao JL; Pang QS; Wang P
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(29):2068-70. PubMed ID: 21029648
[TBL] [Abstract][Full Text] [Related]
24. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
[TBL] [Abstract][Full Text] [Related]
25. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Seiwert TY; Connell PP; Mauer AM; Hoffman PC; George CM; Szeto L; Salgia R; Posther KE; Nguyen B; Haraf DJ; Vokes EE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):515-22. PubMed ID: 17255273
[TBL] [Abstract][Full Text] [Related]
26. Treatment of locally advanced non-small cell lung cancer.
Fidler MJ; Kim AW; Zusag T; Bonomi P
Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
[TBL] [Abstract][Full Text] [Related]
27. Chemoradiation paradigm for the treatment of lung cancer.
Eberhardt W; Pöttgen C; Stuschke M
Nat Clin Pract Oncol; 2006 Apr; 3(4):188-99. PubMed ID: 16596143
[TBL] [Abstract][Full Text] [Related]
28. Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer.
Iranzo V; Bremnes RM; Almendros P; Gavilá J; Blasco A; Sirera R; Camps C
Lung Cancer; 2009 Jan; 63(1):63-7. PubMed ID: 18550204
[TBL] [Abstract][Full Text] [Related]
29. Chemoradiation for unresectable stage III non-small cell lung cancer.
Price KA; Azzoli CG; Gaspar LE
Semin Thorac Cardiovasc Surg; 2008; 20(3):204-9. PubMed ID: 19038729
[TBL] [Abstract][Full Text] [Related]
30. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
Maas KW; El Sharouni SY; Smit EF; Schramel FM
Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176
[TBL] [Abstract][Full Text] [Related]
31. [Surgery and chemoradiation in stage IIIA non-small cell lung cancer].
Hennequin C; Girard N; Mornex F
Cancer Radiother; 2006 Nov; 10(6-7):477-83. PubMed ID: 17046307
[TBL] [Abstract][Full Text] [Related]
32. Locally advanced NSCLC: current state of the art, treatment and future directions.
Choy H; Bonomi PD
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S23-30. PubMed ID: 19780243
[TBL] [Abstract][Full Text] [Related]
33. [Stage III NSCLC. The role of the chemotherapist].
Westeel V
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S95-8. PubMed ID: 18971832
[TBL] [Abstract][Full Text] [Related]
34. Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.
Vokes EE; Leopold KA; Herndon J; Green MR
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-42-S8-45. PubMed ID: 9207317
[TBL] [Abstract][Full Text] [Related]
35. Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer.
Kim DW; Shyr Y; Chen H; Akerley W; Johnson DH; Choy H
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1029-36. PubMed ID: 15913910
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant concurrent chemotherapy and radiotherapy in non-small cell lung cancer.
Ramella S; Ciresa M; Massaccesi M; Franceschini G; D'Angelillo RM; Trodella L
Rays; 2004; 29(4):439-43. PubMed ID: 15852733
[TBL] [Abstract][Full Text] [Related]
37. Chemoradiotherapy of non-small cell lung cancer.
Jassem J
Expert Rev Anticancer Ther; 2002 Aug; 2(4):402-7. PubMed ID: 12647983
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of the unresectable non small cell lung carcinoma].
Spásová I
Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
[TBL] [Abstract][Full Text] [Related]
39. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
40. Optimal therapy for unresectable stage III non-small-cell lung cancer.
Vokes EE
J Clin Oncol; 2005 Sep; 23(25):5853-5. PubMed ID: 16087940
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
